|
|
|
| home > white papers > Soothing the Logistical Headache of Clinical Trials - Equilibrium Travel Management |
|
|
 WHITE PAPERS |
|
Equilibrium Travel Management
|
|
Soothing the Logistical Headache of Clinical Trials
|
|
As many as 30 per cent of subjects on phase three clinical studies drop out. Gruelling schedules, high travel costs and time waiting for expense reimbursement can all be factors in these fall rates, and this can be very problematic, delaying or even leading to the cancellation of the trial. It is crucial to keep subjects motivated, and through efficient travel and expense management, this can be achieved.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
CluePoints Appoints Andy Cooper as New Chief Executive Officer
King of Prussia, PA – December 13, 2022: RBQM leader, CluePoints, has today announced Andy Cooper has been appointed as its new Chief Executive Officer. Cooper succeeds Co-Founder, Francois Torche,
who is stepping back as CEO to focus his full attention on the
strategic direction of CluePoints’ world-leading product portfolio.
More info >> |
|
 |
White Papers |
 |
|
Clinical Trials in Russia Orange Paper: 1st Quarter 2014
Synergy Research Group
In summary, Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia:
1. Fast patient enrollment due to the centralized medical infrastructure.
2. Nearly 100% patient retention
3. GCP trained and certified Investigative Sites generating high quality data
4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >> |
|
|
|
